Stocks and Investing
Stocks and Investing
Thu, October 29, 2020
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
[ Thu, Oct 29th 2020
] - WOPRAI
Joel Beatty Upgraded (VNDA) to Strong Buy and Held Target at $14 on, Oct 29th, 2020
Joel Beatty of Citigroup, Upgraded "Vanda Pharmaceuticals Inc." (VNDA) to Strong Buy and Held Target at $14 on, Oct 29th, 2020.
Joel, nor any peers, have made any analyst calls on VNDA in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources